These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18639648)

  • 1. P53 transcriptional activities: a general overview and some thoughts.
    Millau JF; Bastien N; Drouin R
    Mutat Res; 2009; 681(2-3):118-133. PubMed ID: 18639648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of p53 protein transcriptional activity by chromatin immunoprecipitation.
    Yang-Hartwich Y; Romanoff E; Bingham J; Alvero AB; Mor G
    Methods Mol Biol; 2015; 1219():87-93. PubMed ID: 25308264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation by p53: one protein, many possibilities.
    Laptenko O; Prives C
    Cell Death Differ; 2006 Jun; 13(6):951-61. PubMed ID: 16575405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-Y/p53 liaison: well beyond repression.
    Imbriano C; Gnesutta N; Mantovani R
    Biochim Biophys Acta; 2012 Apr; 1825(2):131-9. PubMed ID: 22138487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress.
    Buschmann T; Potapova O; Bar-Shira A; Ivanov VN; Fuchs SY; Henderson S; Fried VA; Minamoto T; Alarcon-Vargas D; Pincus MR; Gaarde WA; Holbrook NJ; Shiloh Y; Ronai Z
    Mol Cell Biol; 2001 Apr; 21(8):2743-54. PubMed ID: 11283254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
    Millau JF; Bastien N; Bouchard EF; Drouin R
    Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular architecture of tumor suppressor p53.
    Viadiu H
    Curr Top Med Chem; 2008; 8(15):1327-34. PubMed ID: 18991721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor.
    Ho T; Tan BX; Lane D
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of mutant p53 with DNA: guilt by association.
    Kim E; Deppert W
    Oncogene; 2007 Apr; 26(15):2185-90. PubMed ID: 17401427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the p53 transcriptional activity.
    Liu G; Chen X
    J Cell Biochem; 2006 Feb; 97(3):448-58. PubMed ID: 16288459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2.
    Lee SJ; Lim CJ; Min JK; Lee JK; Kim YM; Lee JY; Won MH; Kwon YG
    Cell Death Differ; 2007 Jun; 14(6):1106-16. PubMed ID: 17318220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discerning the function of p53 by examining its molecular interactions.
    Oliner JD
    Bioessays; 1993 Nov; 15(11):703-7. PubMed ID: 8292000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiating the p53 network.
    Menendez D; Inga A; Resnick MA
    Discov Med; 2010 Jul; 10(50):94-100. PubMed ID: 20670604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53: an oncogenic transcription factor.
    Strano S; Dell'Orso S; Di Agostino S; Fontemaggi G; Sacchi A; Blandino G
    Oncogene; 2007 Apr; 26(15):2212-9. PubMed ID: 17401430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities.
    Li DW; Liu JP; Schmid PC; Schlosser R; Feng H; Liu WB; Yan Q; Gong L; Sun SM; Deng M; Liu Y
    Oncogene; 2006 May; 25(21):3006-22. PubMed ID: 16501611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fold recognition of CP2 transcription factors gives new insights into the function and evolution of tumor suppressor protein p53.
    Kokoszynska K; Ostrowski J; Rychlewski L; Wyrwicz LS
    Cell Cycle; 2008 Sep; 7(18):2907-15. PubMed ID: 18787404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
    Kühnel F; Zender L; Wirth T; Schulte B; Trautwein C; Manns M; Kubicka S
    Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 activation by blocking Snail: a novel pharmacological strategy for cancer.
    Lee SH; Park BJ
    Curr Pharm Des; 2011; 17(6):610-7. PubMed ID: 21391911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.